UNITED STATESSECURITIES AND EXCHANGE COMMISSIONWashington, D.C. 20549
Form 6-K
REPORT OF FOREIGN ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934
For the month of September 2026
Commission File Number: 1-32575
Shell plc(Exact name of registrant as specified in its charter)
England and Wales(Jurisdiction of incorporation or organization)
Shell CentreLondon, SE1 7NAUnited Kingdom(Address of principal executive office)
UNITED STATESSECURITIES AND EXCHANGE COMMISSIONWASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): September 25, 2026
FATE THERAPEUTICS, INC.
(Exact name of Registrant as Specified in Its Charter)
Delaware
... (continue reading...)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13a-16 OR 15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934
For the month of September 2026
Commission File Number: 001-42013
SuperX AI Technology Limited
30 Pasir Panjang Road
#06-31, Mapletree Business City
Singapore 117440
(Address of principal executive office)
Indicate by check mark whether... (continue reading...)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13a-16 OR 15d-16 UNDER
THE SECURITIES EXCHANGE ACT OF 1934
For the month of September 2026
Commission File Number: 001-34238
THE9 LIMITED
17 Floor, No. 130 Wu Song Road
Hong Kou District, Shanghai 200080
People’s Republic of China
(Address of principal executive offices)
More SEC Filings
View Older Stories-
Form 497 Tidal Trust III
-
Form 8-K Volato Group, Inc. For: Sep 22
-
Form DEFA14A Strategy Inc
-
Form 8-K 4D Molecular Therapeutic For: Sep 28
-
Form 6-K Sigma Lithium Corp For: Sep 28
-
Form 8-K BGC Group, Inc. For: Sep 28
-
Form 8-K Mirum Pharmaceuticals, For: Sep 25
-
Form 8-K Lakeshore Acquisition For: Sep 22
-
Form 8-K Keros Therapeutics, Inc. For: Sep 28
-
Form 8-K Ainos, Inc. For: Sep 24
-
Form 8-K SHF Holdings, Inc. For: Sep 28
-
Form 8-K Matinas BioPharma Holdin For: Sep 25
-
Form 8-K Strategy Inc For: Sep 14
-
Form 6-K LOGPROSTYLE INC. For: Sep 28
-
Form 6-K Genius Group Ltd For: Sep 28
-
Form 6-K Maris Tech Ltd. For: Sep 28
-
Form 8-K Strive, Inc. For: Sep 28
-
Form 497 Tidal Trust IV
-
Form D Bone Doctors' Barbecue
-
Form 4 Qfin Holdings, Inc. For: Sep 24 Filed by: Yan Andrew Y
-
Form 497J Tidal Trust II
-
Form 6-K COCA-COLA EUROPACIFIC For: Sep 28
-
Form 485BXT Tidal Trust II
-
Form SCHEDULE 13G/A NEKTAR THERAPEUTICS Filed by: Two Seas Capital LP
-
Form 497J Tidal Trust IV
-
Form 6-K INTERMAP TECHNOLOGIES For: Sep 28
-
Form 8-K TransDigm Group INC For: Sep 28
-
Form 8-K NEWS CORP For: Sep 25
-
Form 8-K VALLEY NATIONAL BANCORP For: Sep 27
-
Form 424B3 Pasqal Holding SA
-
Form 8-K Hut 8 Corp. For: Sep 24
-
Form 8-K Soluna Holdings, Inc For: Sep 28
-
Form 8-K Ramaco Resources, Inc. For: Sep 25
-
Form 6-K INLIF Ltd For: Sep 28
-
Form 6-K Pasqal Holding SA For: Sep 28
-
Form 6-K B2GOLD CORP For: Sep 28
-
Form 424B3 WESTPORT FUEL SYSTEMS
-
Form 8-K Eton Pharmaceuticals, For: Sep 28
-
Form 6-K NOVONIX Ltd For: Sep 28
-
Form 6-K Baidu, Inc. For: Sep 28
-
Form 8-K Brixmor Operating Partne For: Sep 27 Filed by: Brixmor Property Group Inc.
-
Form 6-K Inventiva S.A. For: Jun 30
-
Form 6-K Addex Therapeutics Ltd. For: Jun 30
-
Form 4 Vontier Corp For: Sep 24 Filed by: Eatroff Robert L
-
Form S-1/A Londonla Inc.
-
Form S-1 CitroTech Inc.
-
Form 8-K Vestis Corp For: Sep 28
-
Form 8-K Flutter Entertainment For: Sep 28
-
Form 8-K Moleculin Biotech, Inc. For: Sep 28
-
Form 8-K Jaguar Health, Inc. For: Sep 25

